Costa Rica vs New Zealand: New cases tested for RR-/MDR-TB
Costa Rica
100.0%
in 2024
New Zealand
100.0%
in 2014
Costa Rica rank
1st
New Zealand rank
1st
New cases tested for RR-/MDR-TB over time
- Costa Rica
- New Zealand
How they compare
Costa Rica currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2005 it was New Zealand ahead.
Costa Rica ranks 1st and New Zealand ranks 1st of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 100.0% | 99.8% | New Zealand |
| 2010s | 34.3% | 80.5% | 46.2% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Costa Rica or New Zealand?
- Costa Rica, at 100.0% against 100.0% in New Zealand as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Costa Rica and New Zealand?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and New Zealand?
- 7 years are reported by both, from 2005 to 2014.
- How do Costa Rica and New Zealand rank globally for new cases tested for rr-/mdr-tb?
- Costa Rica ranks 1st and New Zealand ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.